FDA Approval of Zepbound for Obstructive Sleep Apnea

FDA approves first medication for obstructive sleep apnea, Zepbound, which helps promote more restful sleep through weight loss. The drug activates hormones to reduce appetite and food intake, improving OSA symptoms. Side effects include nausea, diarrhea, and thyroid C-cell tumor risk.

Health Risks of Fat Loss Shots

Fat loss shots like Ozempic and Zepbound have been linked to over 100 deaths in the US. Concerns exist about counterfeit versions containing insulin. Deaths not directly proven to be caused by injections. Surge in fatalities in 2023 attributed to increased prescriptions.

Shortage of weight-loss drug Zepbound

Shortage of weight-loss drug Zepbound driving customers to extremes, but relief may be near. FDA lists Zepbound as in short supply, leading to challenges in obtaining the medication. Customers are going to great lengths to secure the drug, with some sharing their experiences on Reddit. Shortage expected to be resolved by end of April.